Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Negative Prognostic Relevance of a Specific 3-Gene Cluster in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Blood (2018) 132 (Supplement 1): 4347.

https://doi.org/10.1182/blood-2018-99-112062

Published: 2018

Journal Articles

The ETO2-GLIS2 Fusion Oncogene Alters Early Human Hematopoiesis in an Induced Pluripotent Stem Cells-Derived Model of Pediatric Acute Megakaryoblastic Leukemia

Salvatore Nicola Bertuccio, Marie Cambot, Cécile K Lopez, Larissa Lordier, Alessandro Donada, Zakia Aid, Franco Locatelli, MD PhD, Riccardo Masetti, MDPhD, William Vainchenker, MD PhD, Hana Raslova, PhD, Andrea Pession, MD, Thomas Mercher, PhD

Blood (2017) 130 (Supplement 1): 2512.

https://doi.org/10.1182/blood.V130.Suppl_1.2512.2512

Published: 2017

Journal Articles

Preliminary Results of Gau-PED Study: Prevalence of Gaucher Disease in Paediatric Patients Selected By an Appropriate Diagnostic Algorithm

William Morello, MD, Mirella Filocamo, Marina Stroppiano, Maja Di Rocco, MD, Nicola Tovaglieri, MD, Giovanna Russo, MD, Francesca Furlan, MD, Roberta Burnelli, MD, Andrea Pession, MD

Blood (2017) 130 (Supplement 1): 1187.

https://doi.org/10.1182/blood.V130.Suppl_1.1187.1187

Published: 2017

Journal Articles

Rhob Overexpression Boosts Relapse of t(8;21) RUNX1-RUNX1T1 Rearranged Acute Myeloid Leukemia.

Pigazzi Martina, PhD, Zampini Matteo, PhD, Claudia Tregnago, PhD, Valeria Bisio, PhD, Luca Simula, PhD, Giulia Borella, PhDstudent, Carlo Zanon, PhD, Valentina Serafin, PhD, Benedetta Accordi, PhD, Silvia Campello, PhD, Barbara Buldini, MD PhD, Andrea Pession, MD, Franco Locatelli, MD PhD, Giuseppe Basso, MD

Blood (2017) 130 (Supplement 1): 1192.

https://doi.org/10.1182/blood.V130.Suppl_1.1192.1192

Published: 2017

Journal Articles

Long Non Coding RNA BALR2-CDK6 Axis Influences Cell Differentiation and Metabolic Status of Acute Myeloid Leukemia

Valeria Bisio, PhD, Claudia Tregnago, PhD, Matteo Zampini, PhD, Giulia Borella, PhDstudent, Thilini Fernando, Dinesh S. Rao, MD PhD, Andrea Pession, MD, Franco Locatelli, MD PhD, Giuseppe Basso, MD, Pigazzi Martina, PhD

Blood (2017) 130 (Supplement 1): 3935.

https://doi.org/10.1182/blood.V130.Suppl_1.3935.3935

Published: 2017

Journal Articles

Gene Mutations and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Matilde Y Follo, PhD, Andrea Pellagatti, PhD, Richard N Armstrong, PhD, Stefano Ratti, MD, Sara Mongiorgi, PhD, Annalisa Astolfi, PhD, Valentina Indio, PhD, Cristina Clissa, MD PhD, Domenico Russo, MD, Marco Gobbi, MD, Marilena Barraco, PhD, Sarah Parisi, MD PhD, Andrea Pession, MD, Michele Cavo, MD, Lucia Manzoli, MD, Lucio Cocco, MD, Jacqueline Boultwood, PhD, Carlo Finelli, MD

Blood (2017) 130 (Supplement 1): 5299.

https://doi.org/10.1182/blood.V130.Suppl_1.5299.5299

Published: 2017

Journal Articles

Long-Term Results on Outcome of Children with Hematological Malignancies Transplanted from an Unrelated Donor Enrolled in an Open Label, Randomized Trial Comparing Two Different Dosages of Rabbit Anti-Thymocyte Globulin

Franco Locatelli, MD, Maria Ester Bernardo, MD, Alice Bertaina, MD PhD, Carla Rognoni, PhD, Patrizia Comoli, MD, Attilio Rovelli, MD, Andrea Pession, MD PhD, Franca Fagioli, MD, Claudio Favre, MD, Edoardo Lanino, MD, Giovanna Giorgiani, MD, Pietro Merli, MD, Arcangelo Prete, MD, Marco Zecca, MD

Blood (2016) 128 (22): 1168.

https://doi.org/10.1182/blood.V128.22.1168.1168

Published: 2016

Journal Articles

Role of Nuclear Inositide Signalling and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Matilde Follo, PhD, Sara Mongiorgi, PhD, Cristina Clissa, MD, Annalisa Astolfi, PhD, Domenico Russo, MD, Marco Gobbi, MD, Costanza Bosi, MD, Monica Crugnola, MD, Marta Stanzani, MD, Stefano Ratti, MD, Sarah Parisi, MD, Marilena Barraco, PhD, Lucia Manzoli, MD, Andrea Pession, MD, Lucio Cocco, MD, PhD, Carlo Finelli, MD

Blood (2016) 128 (22): 5091.

https://doi.org/10.1182/blood.V128.22.5091.5091

Published: 2016

Journal Articles

Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40)

Anna Maria Testi, MD, Andrea Pession, MD, David Grimwade, PhD FRCPath, Daniela Diverio, PhD, Christine Ragu, PhD, Sarah Elitzur, MD, Alcira Fynn, MD, Henrik Hasle, MD PhD, Jutte Van der Werff ten Bosch, MD PhD, Owen Smith, MD, Brenda Gibson, MD, Franco Locatelli, MD PhD, Gertjan J.L. Kaspers, MD PhD

Blood (2015) 126 (23): 563.

https://doi.org/10.1182/blood.V126.23.563.563

Published: 2015

Journal Articles

Targeted Inhibition of mTORC1 and mTORC2 by the Active-Site mTOR Inhibitors, PP-242 and OSI-027, Has Cytotoxic Effects In T-Cell Acute Lymphoblastic Leukemia

Camilla Evangelisti, PhD, Francesca Chiarini, PhD, Francesca Ricci, BS, Pierluigi Tazzari, MD, Andrea Pession, MD, PhD, James A McCubrey, PhD, Alberto M. Martelli, MD

Blood (2010) 116 (21): 3242.

https://doi.org/10.1182/blood.V116.21.3242.3242

Published: 2010

Journal Articles

AMP-Dependent Kinase/mTOR Complex 1 Signaling In T-Cell Acute Lymphoblastic Leukemia: Therapeutical Implications

Cecilia Grimaldi, BS, Francesca Chiarini, PhD, Francesca Ricci, BS, Pierluigi Tazzari, MD, Michela Battistelli, PhD, Elisabetta Falcieri, MD, Andrea Pession, MD, PhD, James McCubrey, PhD, Alberto M. Martelli, MD

Blood (2010) 116 (21): 3225.

https://doi.org/10.1182/blood.V116.21.3225.3225

Published: 2010

Journal Articles

Dual Inhibition of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin with NVP-BEZ235 as a New Therapeutic Option for T-Cell Acute Lymphoblastic Leukemia.

Francesca Chiarini, BS, Cecilia Grimaldi, BS, Francesca Ricci, BS, Pierluigi Tazzari, MD, Camilla Evangelisti, PhD, Andrea Pession, MD, PhD, Pasqualepaolo Pagliaro, MD, James McCubrey, PhD, Alberto M. Martelli, MD

Blood (2009) 114 (22): 2025.

https://doi.org/10.1182/blood.V114.22.2025.2025

Published: 2009

Journal Articles

Prevalence and Clinical Correlates of JAK2 Mutations in Pediatric Down Syndrome Acute Lymphoblastic Leukemia.

Amos S. Gaikwad, PhD, Cassia L. Rye, Meenakshi Devidas, PhD, Shai Izraeli, Sr., MD, Sharon E. Plon, MD, PhD, Giuseppe Basso, MD, Andrea Pession, MD, PhD, Karen R. Rabin, MD

Blood (2008) 112 (11): 1506.

https://doi.org/10.1182/blood.V112.11.1506.1506

Published: 2008

Journal Articles

Gene Expression Profiling Differentiates Childhood Acute Lymphoblastic Leukemia in Down Syndrome Versus Non-Down Syndrome Patients.

Karen R. Rabin, MD, Jinhua Wang, PhD, Anna Tsimelzon, PhD, Debra Morrison, PhD, Amos S. Gaikwad, PhD, Laura Hogan, MD, Cassia L. Rye, Susan G. Hilsenbeck, PhD, Meenakshi Devidas, PhD, Nyla A. Heerema, PhD, Andrew J. Carroll, PhD, Giuseppe Basso, MD, William L. Carroll, MD, Andrea Pession, MD, PhD, Deepa Bhojwani, MD

Blood (2008) 112 (11): 1203.

https://doi.org/10.1182/blood.V112.11.1203.1203

Published: 2008

Journal Articles

PI-103, a Dual Inhibitor of Class IA Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin, Has Cytotoxic Activity in T-Cell Acute Lymphoblastic Leukemia Cells: A New Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia.

Francesca Chiarini, BS, Federica Fala, PhD, Francesca Ricci, BS, PierLuigi Tazzari, MD, Annalisa Astolfi, PhD, Andrea Pession, MD, PhD, James McCubrey, PhD, Alberto M. Martelli, MD

Blood (2008) 112 (11): 1921.

https://doi.org/10.1182/blood.V112.11.1921.1921

Published: 2008

Journal Articles

Retrospective Evaluation of 90 Children with Essential Thrombocytemia: The AIEOP Experience

Maria Caterina Putti, MD, Fiorina Giona, MD, Caterina Consarino, MD, Gian Mario Fiori, MD, Paola Giordano, MD, Saverio Ladogana, MD, Momcilo Jankovic, MD, Concetta Micalizzi, MD, Andrea Pession, MD, PhD, Paolo Pierani, MD, Ugo Ramenghi, MD, Margherita Scapin, PhD, Luciana Teofili, MD, Fabio Tucci, MD, Katia Tettoni, MD, Andrea Giulio Zanazzo, Maria Luigia Randi, MD

Blood (2008) 112 (11): 664.

https://doi.org/10.1182/blood.V112.11.664.664

Published: 2008

Journal Articles

The Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents with Recurring Hodgkin’s Lymphoma: An EBMT Study on 151 Patients.

Alexander Claviez, MD, Carmen Canals, Marc Boogaerts, MD, Jerry Stein, MD, Stephen Mackinnon, MD, Rodrigo Martino, MD, Andrea Pession, MD, Shimon Slavin, MD, Charles Craddock, MD, Ioanna Sakellari, MD, Paolo Corradini, MD, Alessandro Rambaldi, MD, Meinolf Suttorp, MD, Giorgio Dini, MD, Anna Sureda, MD, Norbert Schmitz, MD

Blood (2007) 110 (11): 3061.

https://doi.org/10.1182/blood.V110.11.3061.3061

Published: 2007

Journal Articles

Intravenous (i.v.) or Oral (os) Busulphan (BUS) in Children Prior to Autologous (Auto) or Allogeneic (Allo) Stem Cell Transplantation (SCT): Pharmacokinetics (PK), Toxicity and Compliance.

Arcangelo Prete, MD, Antonella Bartoli, MD, Claudia Castellini, MD, Roberto Rondelli, MD, Riccardo Masetti, MD, Andrea Pession, MD, Mario Regazzi-Bonora, MD

Blood (2005) 106 (11): 5320.

https://doi.org/10.1182/blood.V106.11.5320.5320

Published: 2005

Journal Articles

Unrelated Donor Bone Marrow Transplantation for Class I-II Thalassemia Pediatric Patients.

Franco Locatelli, MD, Claudio Giardini, MD, Sebastian Giebel, MD, Franca Argiolu, MD, Andrea Pession, MD, Franca Fagioli, MD, Giovanna Giorgiani, MD, Giorgio La Nasa, MD

Blood (2005) 106 (11): 562.

https://doi.org/10.1182/blood.V106.11.562.562

Published: 2005

Journal Articles

High Dose Therapy (HDCT) and Autologous Haematopoietic Stem Cell Transplantation (aSCT) in Paediatric Patients with Recurrent or Refractory Hodgkin’s Disease (HD): Results and Outcome.

Arcangelo Prete, MD, Federico Bonetti, MD, Roberto Rondelli, MD, Simone Cesaro, MD, Sandro Dallorso, MD, Claudio Favre, MD, Franca Fagioli, MD, Chiara Messina, MD, Roberta Burnelli, MD, Franco Locatelli, MD, Andrea Pession, MD

Blood (2005) 106 (11): 2088.

https://doi.org/10.1182/blood.V106.11.2088.2088

Published: 2005

NARROW

Negative Prognostic Relevance of a Specific 3-Gene Cluster in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

The ETO2-GLIS2 Fusion Oncogene Alters Early Human Hematopoiesis in an Induced Pluripotent Stem Cells-Derived Model of Pediatric Acute Megakaryoblastic Leukemia

Preliminary Results of Gau-PED Study: Prevalence of Gaucher Disease in Paediatric Patients Selected By an Appropriate Diagnostic Algorithm

Rhob Overexpression Boosts Relapse of t(8;21) RUNX1-RUNX1T1 Rearranged Acute Myeloid Leukemia.

Long Non Coding RNA BALR2-CDK6 Axis Influences Cell Differentiation and Metabolic Status of Acute Myeloid Leukemia

Gene Mutations and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Long-Term Results on Outcome of Children with Hematological Malignancies Transplanted from an Unrelated Donor Enrolled in an Open Label, Randomized Trial Comparing Two Different Dosages of Rabbit Anti-Thymocyte Globulin

Role of Nuclear Inositide Signalling and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40)

Targeted Inhibition of mTORC1 and mTORC2 by the Active-Site mTOR Inhibitors, PP-242 and OSI-027, Has Cytotoxic Effects In T-Cell Acute Lymphoblastic Leukemia

AMP-Dependent Kinase/mTOR Complex 1 Signaling In T-Cell Acute Lymphoblastic Leukemia: Therapeutical Implications

Dual Inhibition of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin with NVP-BEZ235 as a New Therapeutic Option for T-Cell Acute Lymphoblastic Leukemia.

Prevalence and Clinical Correlates of JAK2 Mutations in Pediatric Down Syndrome Acute Lymphoblastic Leukemia.

Gene Expression Profiling Differentiates Childhood Acute Lymphoblastic Leukemia in Down Syndrome Versus Non-Down Syndrome Patients.

PI-103, a Dual Inhibitor of Class IA Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin, Has Cytotoxic Activity in T-Cell Acute Lymphoblastic Leukemia Cells: A New Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia.

Retrospective Evaluation of 90 Children with Essential Thrombocytemia: The AIEOP Experience

The Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents with Recurring Hodgkin’s Lymphoma: An EBMT Study on 151 Patients.

Intravenous (i.v.) or Oral (os) Busulphan (BUS) in Children Prior to Autologous (Auto) or Allogeneic (Allo) Stem Cell Transplantation (SCT): Pharmacokinetics (PK), Toxicity and Compliance.

Unrelated Donor Bone Marrow Transplantation for Class I-II Thalassemia Pediatric Patients.

High Dose Therapy (HDCT) and Autologous Haematopoietic Stem Cell Transplantation (aSCT) in Paediatric Patients with Recurrent or Refractory Hodgkin’s Disease (HD): Results and Outcome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only